tiprankstipranks
Bloomios (BLMS)
OTHER OTC:BLMS
US Market

Bloomios (BLMS) Stock Price & Analysis

10 Followers

BLMS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.75
Previous Close$0.01
Volume410.00K
Average Volume (3M)N/A
Market Cap
$51.58K
Enterprise Value$1.21M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$1.16M
Price to Earnings (P/E)>-0.1
Beta-0.88
May 10, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.93
Shares Outstanding64,473,246
10 Day Avg. Volume144,000
30 Day Avg. VolumeN/A
Standard Deviation0.72
R-Squared0.00419
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.03
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit0.54
Enterprise Value/Ebitda-0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

12.64%0.00%0.00%87.36%
12.64%
Insiders
0.00%
Mutual Funds
0.00% Other Institutional Investors
87.36% Public Companies and
Individual Investors

BLMS FAQ

What was Bloomios’s price range in the past 12 months?
Bloomios lowest stock price was <$0.01 and its highest was $0.75 in the past 12 months.
    What is Bloomios’s market cap?
    Currently, no data Available
    When is Bloomios’s upcoming earnings report date?
    Bloomios’s upcoming earnings report date is May 10, 2024 which is in 5 days.
      How were Bloomios’s earnings last quarter?
      Bloomios released its earnings results on Nov 13, 2023. The company reported -$0.424 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.424.
        Is Bloomios overvalued?
        According to Wall Street analysts Bloomios’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Bloomios pay dividends?
          Bloomios does not currently pay dividends.
          What is Bloomios’s EPS estimate?
          Bloomios’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Bloomios have?
          Bloomios has 64,473,240 shares outstanding.
            What happened to Bloomios’s price movement after its last earnings report?
            Bloomios reported an EPS of -$0.424 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Bloomios?
              Currently, no hedge funds are holding shares in BLMS
              ---

              Bloomios Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Bloomios

              XLR Medical Corp. is a blank check company, which engages in pursuing potential new business opportunity by way of a merger and acquisition with an unidentified company, an acquisition of assets, and other form of business combination. The company was founded on February 2, 2001 and is headquartered in Long Beach, NY.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Bellerophon
              Bioline RX Ltd Sponsored ADR
              BioLife Solutions
              Suncliff Inc
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis